Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Local Residents to Host Scotch & Sangria for Parkinson’s Research at Sear House in Closter, NJ, on Thursday, March 2

Proceeds From Fourth Annual Helping Hours Event Benefit Parkinson’s Foundation

WHAT:  Enjoy post-work cocktails to support the Parkinson’s cause. Parkinson’s Foundation board member, Stephanie Goldman and her fellow co-chairs are inviting their community to Scotch & Sangria, their fourth annual Helping Hours event. The evening will feature a special tasting of assorted scotch and sangria, gourmet dinner and silent auction. Proceeds benefit the Foundation.

WHO:  The Parkinson’s Foundation, led by event Co-Chairs Stephanie Goldman of Norwood, Amy Sole of Mountain Lakes and Doug Stern of Demarest, NJ. The evening is a signature Parkinson’s Foundation Helping Hours event, where friends can enjoy a night out while supporting Parkinson’s research. The mission of the Parkinson’s Foundation, formed in August 2016 by the merger of PDF and the National Parkinson Foundation, is to invest in promising scientific research that will end Parkinson’s disease and improve the lives of people with Parkinson’s, and their families, through improved treatments, support and the best care.

WHY:  Co-Chairs Ms. Goldman, Ms. Sole and Mr. Stern, formed this event in honor of their loved ones touched by Parkinson’s. Ms. Goldman adds, “There’s still no cure for Parkinson’s disease. That’s why my co-chairs and I are driven to bring our community together each year to raise more awareness and critical funds to support the Parkinson’s Foundation’s work to end Parkinson’s for the one million people in the US, who like my father, live with Parkinson’s disease.” Since 2014, the trio’s Helping Hours events have raised over $80,000 for Parkinson’s research.

WHEN:  Thursday, March 2, 7:00 PM to 10:00 PM.

WHERE:  Sear House, 411 Piermont Road, Closter, NJ 07624

Monday, January 30, 2017
In Memory of Robert Traurig
Wednesday, July 18, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member Robert (Bob) Traurig. From 2004 to 2015, he was a member of the Foundation’s board of directors. Bob is survived by his wife Jacqueline, his daughters Madeline Sackel and Wendy Traurig.

New Study Shows 1.2 Million People in the United States Estimated to be Living with Parkinson’s Disease by 2030
Tuesday, July 10, 2018

Parkinson’s Foundation Reveals Most Comprehensive Estimate of
Parkinson’s Prevalence in North America since the 1970’s

Parkinson’s Foundation Elects Howard D. Morgan Chairman of the Board
Tuesday, June 26, 2018

MIAMI & NEW YORK — June 26, 2018 — The Parkinson’s Foundation today announced the election of Howard D. Morgan as chairman of its board of directors. Mr. Morgan, who previously served as the Vice Chair of the nonprofit organization’s board, is a Partner and the Senior Managing Director of Argand Partners in New York.

Parkinson’s Foundation Announces Five New Members of its People with Parkinson’s Advisory Council
Wednesday, June 13, 2018

NEW YORK & MIAMI — June 13, 2018 — The Parkinson’s Foundation today announced five new members of its People with Parkinson’s Advisory Council.

The Parkinson’s Foundation 2018 Gala in New York City Tuesday, May 8, 2018
Monday, May 14, 2018

The Parkinson’s Foundation 2018 Gala was held at Cipriani 25 Broadway in New York City on Tuesday, May 8, 2018.

Parkinson’s Foundation Adds Alison Herman to its Board of Directors
Tuesday, May 8, 2018

MIAMI – May 9, 2018 – The Parkinson’s Foundation today announced the election of Alison Herman to its board of directors. Herman is senior counsel at Southern Glazer’s Wine & Spirits, a company which has generously supported Parkinson’s Foundation fundraisers.

Statement on Nuplazid Drug
Tuesday, April 10, 2018

On 4/9/18, CNN published an article on the FDA-approved drug, Nuplazid, used to treat hallucinations and psychosis in Parkinson’s disease. The article investigates FDA data showing the number of reported deaths with people taking Nuplazid. Nuplazid was approved by the FDA in 2016 and is manufactured by Acadia Pharmaceuticals.

Parkinson’s Foundation Adds John D. Thomopoulos to its Board of Directors
Monday, March 19, 2018

MIAMI & NEW YORK – March 19, 2018 – The Parkinson’s Foundation today announced the election of John D. Thomopoulos to its board of directors. Thomopoulos is a partner at Ernst & Young.

In Memory of Edythe Kay Marsa
Monday, March 12, 2018

The Parkinson’s Foundation mourns the loss of emeritus board member, Edythe (Edy) Kay Marsa. From 1993 to 2014, she was a member of the Foundation’s board of directors and served on several committees. Edy is survived by her husband William Marsa, who founded the Herbert Kay Parkinson Chapter in honor of her first husband who passed away due to complications from Parkinson’s disease.

Parkinson’s Foundation Announces New Genetic Initiative Connecting Parkinson’s Genetic Data with Clinical Care
Tuesday, March 6, 2018

MIAMI & NEW YORK—March 6, 2018—The Parkinson’s Foundation today announced a new initiative offering genetic testing and counseling to Parkinson’s patients within its Center of Excellence network.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.